CytoSorbents Corporation (CTSO)

[andy55q]

A CLINICAL EXPERIENCE OF USING EXTRACORPOREAL CYTOKINE ADSORPTION DEVICE (CYTOSORB®) IN A CASE OF DENGUE FEVER Zafer Ali Khan 1

1Director, Department of Internal Medicine, Noble Hospital, Magarpatta Road, Hadapsar, Pune, India.

BACKGROUND Dengue is a mosquito-borne viral disease transmitted by Aedes aegypti and Aedes albopictus. It is hypothesised that elevated cytokines such as tumour necrosis factor alpha (TNF-a), interleukins and interferon gamma (IFN-?) during severe dengue causes damage to the endothelial cells of the capillaries that results in fluid leakage. A novel Extracorporeal Cytokine Adsorption Device (ECAD) CytoSorb® targets the cytokines helps modulate immune response and prevent multiorgan dysfunction syndrome.

J. Evid. Based Med. Healthc., pISSN- 2349-2562, eISSN- 2349-2570/ Vol. 3/Issue 87/Oct. 31, 2016

http://www.jebmh.com/data_pdf/Zafer%20Ali%20Khan%20-%20FINAL.pdf